TY  - JOUR
T1  - Clinical Efficacy of LivPro ® Herbal Medicine among Hepatitis C Patients Pakistan: Longitudinal Interventional Study
A1  - Irfan Shahid
A1  - Kashif Maqbool Khan
A1  - Tahir Mehmood Khan
A1  - Muhammad Saeed Imran
A1  - Nabeel Shahid
A1  - Farah Nofal Alnafoosi
A1  - Mirza Rafi Baig
A1  - Yaser Mohammed Al-Worafi
JF  - Archives of Pharmacy Practice
JO  - Arch Pharm Pract
SN  - 2320-5210
Y1  - 2021
VL  - 12
IS  - 4
DO  - 10.51847/v5lmbrLQNQ
SP  - 54
EP  - 57
N2  - The current study aims to investigate the hepatoprotective effects of LivPro® among hepatitis C patients. An interventional study was performed among n=89 hepatitis C patients. The duration of the study was 3 months and the assessment for liver function, ELISA, and Viral load was performed monthly for the patients recruited in this study. Mean difference was measured and at a Confidence Interval (CI 95%) p-value less than 0.05 was considered statistically significant. This interventional study was comprised of 89 patients who directly participated in this study. Of whom 52 (58.0%) were men and the remaining 42% were women. All the patients were hepatitis C positive at the time of recruitment of study. Overall, it is observed that improvement in ALT at the endpoint assessment was -23.13 [ -31.96 - -14.30] in comparison to the baseline (p=
UR  - https://archivepp.com/article/clinical-efficacy-of-livpro-herbal-medicine-among-hepatitis-c-patients-pakistan-longitudinal-inter-pug7gi6fsski3c2
ER  -